In documents released on Tuesday, the FDA said that there is conflicting evidence about the risk of Yaz, but that the information should appear in labeling used by doctors and patients.
Statements from the FDA scientists say that they believe that there is support for increased risk and the labeling should reflect that. The FDA will ask a panel of outside experts to share their expertise and weigh in on whether some women should not take the drugs.
Other than blood clots, Yaz and its generic forms of the drug have been linked to cause...
- Heart Attacks
- Benign Liver Tumors
- Bleeding Inside the Brain
- High Blood Pressure
If you or a loved one has been injured from taking Yaz, Yasmin, Ocella, or any of the generic forms, you need our help. Our Toledo, Ohio Yaz injury attorneys are experienced at handling these types of cases and will work hard with you to get you the settlement you need and deserve.
Call our office at toll free 800.637.8170 to speak with a Yaz injury attorney today and to set up your free consultation. Also, request your FREE copy our Yaz Birth Control Serious Health Problems Special Report written by our experienced Yaz injury lawyers at The Charles E. Boyk Law Offices, LLC.
Post a comment
Post a Comment to "Yaz labels may include more blood cot information"To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."